Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Zhonglian He"'
Autor:
Wenmin Liao, Rong He, Zhonglian He, Nan Shi, Dan Li, Aihua Zhuang, Feng Gan, Ying Sun, Chaofeng Li
Publikováno v:
Journal of Medical Internet Research, Vol 26, p e51412 (2024)
BackgroundTertiary hospitals in China are confronted with significant challenges due to limited spatial capacity and workforce constraints, leading to saturated allocation of medical resources and restricted growth in medical service provision. The i
Externí odkaz:
https://doaj.org/article/89c34462351b4bc9b028a6b02da426dd
Autor:
Weicheng Lu, Weifeng Hong, Haibo Qiu, Zhongguo Zhou, Zhonglian He, Weian Zeng, Weiqiang Zhong, Jingdun Xie
Publikováno v:
Cancer Medicine, Vol 11, Iss 20, Pp 3873-3885 (2022)
Abstract Background Liver cancer is one of the most deadly and prevalent cancers. A routine follow‐up plan for liver cancer is crucial but limited. In the present study, we aimed to disclose possible risk factors and critical survival time windows
Externí odkaz:
https://doaj.org/article/c1790c33332c41f28ae3c3bc9150e20a
Publikováno v:
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-8 (2019)
Abstract Background Patients with HBsAg-positive gastric cancer (GC) are a heterogeneous group, and it is not possible to accurately predict the overall survival (OS) in these patients. Methods We developed and validated a nomogram to help improve pr
Externí odkaz:
https://doaj.org/article/86fdb002b7bf4ffa8335c6804191e438
Autor:
Xueping Wang, Zhonglian He, Wen Liu, Runkun Han, Huilan Li, Shuqin Dai, Lin Zhang, Minjie Mao
Publikováno v:
Journal of Oncology. 2022:1-11
Immune checkpoint inhibitors (ICI) have created an advanced shift in the treatment of lung cancer (LC), but the existing biomarkers were not in clinical and widespread use. The purpose of this study was to develop a new nomogram with immune factors u
Autor:
Lin Zhang, Minjie Mao, Xing-zhuo Liu, Zhonglian He, Yiling Song, Xueping Wang, Wen Liu, Huilan Li
Publikováno v:
SSRN Electronic Journal.
Background: The development of immune checkpoint inhibitors (ICI) has resulted in a shift in the treatment of lung cancer (LC); however, biomarkers of clinical efficacy have not been fully validated. In this study, a novel nomogram with immune factor
Autor:
Wanli Liu, Xueping Wang, Peidong Chi, Jia-rui Su, Zhonglian He, Shuqin Dai, Lin Zhang, Min Jie Mao
Publikováno v:
Journal of Cancer
Aims: The levels of coagulation system tests have been studied in various cancers. In this study, our aim is to evaluate the prognostic value of pretreatment plasma coagulation tests in hepatocellular carcinoma (HCC) patients. Patient and methods: A
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-8 (2019)
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-8 (2019)
Background Patients with HBsAg-positive gastric cancer (GC) are a heterogeneous group, and it is not possible to accurately predict the overall survival (OS) in these patients. Methods We developed and validated a nomogram to help improve prediction
Publikováno v:
SSRN Electronic Journal.
Autor:
Zhonglian He, Huilan Li, Shuqin Dai, Jian-Hua Lin, Minjie Mao, Wanming Hu, Yi He, Lin Zhang, Xueping Wang, Wanli Liu
Publikováno v:
International journal of biological sciences. 15(1)
The aim of this study is to establish and validate an effective prognostic nomogram in patients with AFP-negative hepatocellular carcinoma (HCC). The nomogram was based on a primary cohort that consisted of 419 patients with clinicopathologically dia